MUSE Healthcare launches predictive hospice tool with Homecare Homebase
Homecare Homebase (HCHB), the nation’s #1 software for home health and hospice, has partnered with MUSE Healthcare of St. Paul to offer enhanced hospice care during the most critical times of a patient’s care journey.
DALLAS, TX – Homecare HomebaseSM (HCHB), the nation’s #1 software for home health and hospice, has partnered with MUSE Healthcare of St. Paul to offer enhanced hospice care during the most critical times of a patient’s care journey. The new product uses sophisticated modeling and machine learning to better predict, prepare and provide for hospice patients in the last 7-12 days of life.
The fast-growing, complex and sensitive hospice service area offers unique challenges for providers seeking to allocate resources when and where they’re needed most. The MUSE solution is designed to address a well-documented gap in end of life care and ensure that every patient transitions with exceptional dignity, comfort and attention.
Tom Maxwell, Co-Founder of MUSE Healthcare said the data science company’s extraordinary insight comes from a vast, ever-growing patient data pool that can accurately predict outcomes based on the most subtle, yet wide-ranging metrics. “We know that the average late-stage patient is often underserved. Our whole goal is to arm hospice staff with information and enable them to offer more caring hospice visits to patients and families in the last 7-12 days of life, with a greater sense of satisfaction for everyone.”
According to Homecare Homebase Chief Strategy Officer Scott Pattillo, patient and family satisfaction is essential in building stronger referrals and long-term business success. “The MUSE product is the perfect fit for our HCHB Business Connect Suite of interoperability products and adds incredible value to our robust hospice solution through its integration. When we can empower exceptional care during a patient’s final days and help our customers better manage their resources, it’s a win/win for everyone.”
About MUSE Healthcare
Muse Healthcare was founded in 2019 by three leading hospice industry professionals — Jennifer Maxwell, Tom Maxwell and Bryan Mosher. Their mission is to equip clinicians with world-class analytics to ensure every hospice patient transitions with unparalleled quality and dignity. Muse’s predictive model considers hundreds of thousands of data points from millions of visits to identify which hospice patients are most likely to transition within 7-12 days. The science that powers Muse is considered a true deep learning neural network – the only one of its kind in the hospice space. When hospice care providers can more accurately predict when their patients will transition, they can ensure their patients and their patients' families receive the care that matters most in the final days and final hours of a patient's life.
For more information, visit musehc.com.
About Homecare Homebase, LLC
Homecare Homebase (HCHB) is a Dallas-based software leader offering hosted, cloud-based
solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for homecare and hospice agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and faster payment. Founded by industry veterans in 1999, the company is now part of the Hearst Health Network.
For more information visit hchb.com or call us toll-free at 1-866-535-HCHB (4242).
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, and MHK (formerly MedHOK—Medical House of Knowledge) (www.hearsthealth.com). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth or LinkedIn